Attention Deficit/Hyperactivity Disorder and Sleep Studies for Children and Adolescents

Hasbro Children's Hospital is currently seeking children and adolescents with attention deficit/hyperactivity disorder (ADHD)and insomnia to participate in a study examining the effects of atomoxetine on ADHD-related insomnia.

You are eligible to participate if you:

Are between the ages of 6 and 17
Have diagnosed ADHD
Have difficulty sleeping

Those with a history of chronic medical or psychiatric illness are not eligible to participate.

All participants will be compensated for their time and travel.

For more information, call 401-444-8815.

Back | More clinical trials